Sort
16,300 grants matching “fatty liver disease”
Mechanisms of Diabetic Hyperphagia and Insulin Resistance
$384,986Michael W Schwartz · University Of Washington · R01 · FY2008 · DK
Mechanisms of Diabetic Hyperphagia and Insulin Resistance
$384,986Michael W Schwartz · University Of Washington · R01 · FY2009 · DK
Nuclear envelope and predisposition to hepatic neoplasia
$384,860Ji-Yeon Shin · Hackensack University Medical Center · R01 · FY2024 · CA
Lipoproteins in Cardiovascular Biology and Pathology
$384,856Monty Krieger · Massachusetts Institute Of Technology · P01 · FY2010 · HL
TET1 in non-alcoholic fatty liver disease development
$384,829Chiung-Kuei Huang · Tulane University Of Louisiana · R01 · FY2025 · DK
Lipids, Inflammation and Insulin Action
$384,805Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2010 · DK
Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2
$384,787David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2016 · DK
Regulation of Cholesterol Catabolism by Bile Acids
$384,780Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2017 · DK
Taskforce for Obesity Research at Southwestern (TORS)
$384,760Jay D Horton · Ut Southwestern Medical Center · UL1 · FY2011 · DE
Role of cholesteryl ester transfer protein in cellular lipid homeostasis
$384,650Richard E Morton · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Nuclear Receptor Functional Profiling in Metabolism and Disease
$384,630Ronald M. Evans · Baylor College Of Medicine · U19 · FY2011 · DK
Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults
$384,578Tiffany Lashaun Carson · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
The Musculoskeletal Cost of Organ Repair
$384,518Leonidas G Koniaris · Oregon Health & Science University · R01 · FY2023 · GM
Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis
$384,492John Daniel Clarke · Washington State University · R01 · FY2024 · ES
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
$384,442Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2014 · HL
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients
$384,387Michael B Rothberg · Cleveland Clinic Foundation · R01 · FY2023 · HS
Ketone Body Metabolism and Integrated Metabolic Homeostasis
$384,375Peter A Crawford · University Of Minnesota · R01 · FY2018 · DK
Functions of intracellular lipid-binding proteins
$384,363Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · DK
A novel CREBH-derived hepatokine regulates triglyceride metabolism
$384,272Kezhong Zhang · Wayne State University · R01 · FY2024 · DK
Elucidating and targeting beta-cell senescence and its SASP
$384,257Cristina Aguayo-Mazzucato · Joslin Diabetes Center · R01 · FY2022 · DK
Hypoxia-Inducible Factors in Liver Metabolism
$384,249Volker H. Haase · Vanderbilt University · R01 · FY2009 · DK
The role of Kupffer cells in alcohol-induced liver disease
$384,240Yasuko Iwakiri · Yale University · R01 · FY2017 · AA
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
$384,000M Mahmood Hussain · Nyu Winthrop Hospital · R01 · FY2017 · HL
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
$384,000M Mahmood Hussain · Nyu Winthrop Hospital · R01 · FY2019 · HL
Circadian Regulation of Atherosclerosis
$384,000Xiaoyue Pan · Nyu Winthrop Hospital · R56 · FY2017 · HL